| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 01/29/2004 | WO2004009759A2 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 01/29/2004 | WO2004009617A1 NOVEL Notch-ORIGIN POLYPEPTIDES AND BIOMARKERS AND REAGENTS USING THE SAME |
| 01/29/2004 | WO2004009104A1 Megasphaera elsdenii strain and its uses |
| 01/29/2004 | WO2004009103A1 Probiotics for gut neuromuscular functions |
| 01/29/2004 | WO2004009031A2 Lactobacillus strains and uses therefor |
| 01/29/2004 | WO2004008850A2 Process for sonicating plant seeds |
| 01/29/2004 | WO2004008838A2 Method for processing cereal material |
| 01/29/2004 | WO2003085098A3 Identification of virulence associated regions rd1 and rd5 enabling the development of improved vaccines of m. bovis bcg and m. microti |
| 01/29/2004 | WO2003054207A3 Fermentation process for the preparation of l-amino acids using coryneform bacteria |
| 01/29/2004 | WO2003054157A3 Dna encoding novel cyclic gmp dependent protein kinases from two protozoal sources for use as chemotherapeutic targets for antiprotozoal agents |
| 01/29/2004 | WO2003044186A3 Novel gene cluster of pederin biosynthesis genes |
| 01/29/2004 | WO2003029478A3 Cultivation of dispersed mycobacteria |
| 01/29/2004 | WO2003020111A3 Alternatively spliced circulating tissue factor |
| 01/29/2004 | WO2003018825A3 Method for producing vitamin b12 |
| 01/29/2004 | WO2003018766A3 Self-processing plants and plant parts |
| 01/29/2004 | WO2003008451A3 Modification of human variable domains |
| 01/29/2004 | WO2003004662A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 01/29/2004 | WO2002099060A3 Dgks as modifiers of the p53 pathway and methods of use |
| 01/29/2004 | WO2002083900A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/29/2004 | WO2002078631A3 Improved conditionally replicating vectors for inhibiting viral infections |
| 01/29/2004 | WO2002072794A3 Immunoglobulin superfamily proteins |
| 01/29/2004 | WO2002070737A3 Compositions and methods relating to osteoarthritis |
| 01/29/2004 | WO2002066615A9 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 01/29/2004 | US20040019929 Aromatic amino acid biosynthetic enzymes |
| 01/29/2004 | US20040019185 Process for preparing purified active monomer of bone-derived factor |
| 01/29/2004 | US20040018964 Glycosyltransferase gene gtfE from Amycolatopsis orientalis |
| 01/29/2004 | US20040018626 Replacement of immunoglobulin in endogenous cells; forming embryos stem cell |
| 01/29/2004 | US20040018624 Compositions and methods for making mutations in cell lines and animals |
| 01/29/2004 | US20040018618 Genetic engineering; hybrid proteins; gene expression; human gene therapy |
| 01/29/2004 | US20040018609 Water, sewage treatment; diffusion of nutrients; glucose and biodegradation polymer; fixed bed fermentation |
| 01/29/2004 | US20040018602 Adjust tocopherol in plant cells; nucleic acid construct |
| 01/29/2004 | US20040018600 Microbial conversion of glucose to para-hydroxystyrene |
| 01/29/2004 | US20040018597 Methods for making polyketides |
| 01/29/2004 | US20040018596 Process for producing polypeptide having disulfide bond |
| 01/29/2004 | US20040018595 Production of recombinant bmp-2 |
| 01/29/2004 | US20040018591 Methods and compositions for protein expression and purification |
| 01/29/2004 | US20040018589 Induce immunology response; in situ proteolysis |
| 01/29/2004 | US20040018573 Production of functional antibodies in filamentous fungi |
| 01/29/2004 | US20040018542 Phosphodiesterase enzymes |
| 01/29/2004 | US20040018516 Ixodes scapularis tissue factor pathway inhibitor |
| 01/29/2004 | US20040018514 Nucleotide sequence derived from Listeria inocua |
| 01/29/2004 | US20040018505 Aminoacyl trna synthetases |
| 01/29/2004 | US20040018503 Nucleotide sequence of the haemophilus influenza Rd genome, fragments thereof, and uses thereof |
| 01/29/2004 | US20040018274 Method of producing active dry yeast |
| 01/29/2004 | US20040018215 Methods for the in vitro culture of sporozoea sp. and uses thereof |
| 01/29/2004 | US20040018209 Abundant extracellular products and methods for their production and use |
| 01/29/2004 | US20040018196 Proteins and nucleic acids encoding same |
| 01/29/2004 | US20040018191 Neutralizing human anti-IGFR antibody |
| 01/29/2004 | US20040018168 Application of volatile antibiotics and non-volatile inhibitors from Muscodor spp. to control harmful microbes in human and animal wastes |
| 01/29/2004 | CA2493910A1 Process for increasing the yield of lipid and omega-3 fatty acid in seaweed culture |
| 01/29/2004 | CA2493679A1 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics |
| 01/29/2004 | CA2493255A1 Probiotics for gut neuromuscular functions |
| 01/29/2004 | CA2493121A1 Lactobacillus strains and uses therefor |
| 01/29/2004 | CA2492805A1 Megasphaera elsdenii strain and its uses |
| 01/29/2004 | CA2492498A1 Flea and tick octopamine receptor nucleic acid molecules, proteins and uses thereof |
| 01/29/2004 | CA2489982A1 Preparation of microbial oil containing polyunsaturated fatty acids |
| 01/29/2004 | CA2487400A1 Methods of enhancing yields of soluble proteins |
| 01/29/2004 | CA2467691A1 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 01/28/2004 | EP1384782A1 Method of detecting the expression of aspergillus gene |
| 01/28/2004 | EP1384778A1 Process for synthesizing protein using cell-free protein synthesis system |
| 01/28/2004 | EP1384726A2 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 01/28/2004 | EP1384483A1 Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function |
| 01/28/2004 | EP1384067A2 Concentration and purification of analytes using electric fields |
| 01/28/2004 | EP1383931A1 Nucleic acid vaccines for prevention of flavivirus infection |
| 01/28/2004 | EP1383927A2 New polynucleotides and polypeptides of the erythropoietin gene |
| 01/28/2004 | EP1383899A2 Enzymatic method for the enantioselective reduction of keto compounds |
| 01/28/2004 | EP1383898A2 A process for the fermentative preparation of d-pantothenic acid and/or its salts |
| 01/28/2004 | EP1383897A2 Self-containing lactococcus strain |
| 01/28/2004 | EP1383895A2 Polynucleotides and polypeptides of the ifnalpha-5 gene |
| 01/28/2004 | EP1383893A2 Proteins and nucleic acids encoding same |
| 01/28/2004 | EP1383892A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/28/2004 | EP1383891A2 Method for the stable inversion of dna sequence by site-specific recombination and dna vectors and transgenic cells thereof |
| 01/28/2004 | EP1383890A2 Mutants of desoxycytidine kinase having extended enzymatic activity |
| 01/28/2004 | EP1383886A2 D-hydantoinase from ochrobactrum anthropi |
| 01/28/2004 | EP1383884A2 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon |
| 01/28/2004 | EP1383883A2 Asthma-associated snps around microsatellite marker d2s308 and identification of human prolyl-oligopeptidase-dpp10 |
| 01/28/2004 | EP1383874A1 Variants of lipoxygenase and their use |
| 01/28/2004 | EP1383865A2 Methods for the production of tyrosine, cinnamic acid and para-hydroxycinnamic acid |
| 01/28/2004 | EP1383864A2 Isoprenoid production |
| 01/28/2004 | EP1383798A2 Transporters and ion channels |
| 01/28/2004 | EP1383791A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/28/2004 | EP1383790A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr protein, and uses thereof |
| 01/28/2004 | EP1383789A2 Proteins associated with cell growth, differentiation, and death |
| 01/28/2004 | EP1383784A1 A hepatitis b virus surface antigen mutant and methods of detection thereof |
| 01/28/2004 | EP1383783A2 Leinamycin biosynthesis gene cluster and its components and their uses |
| 01/28/2004 | EP1383534A2 Chlamydia vaccine composition |
| 01/28/2004 | EP1383530A2 Laminin 5, 13 and 14 and uses thereof |
| 01/28/2004 | EP1383528A2 Epitope sequences |
| 01/28/2004 | EP1383393A2 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 01/28/2004 | EP1226229B1 Method of freeze-drying different microorganisms |
| 01/28/2004 | EP1021528B1 Methods of refolding proteins by use of zwitterionic low molecular weight agents |
| 01/28/2004 | EP0968291B1 Antibody fragment-polymer conjugates |
| 01/28/2004 | EP0636030B1 Pasteurella haemolytica type a-1 bacterin-toxoid vaccine |
| 01/28/2004 | CN1471583A Packaging of positive-strand RNA virus replicon particles |
| 01/28/2004 | CN1471582A Methods for producing a polypeptide using a consensus translational initiator sequence |
| 01/28/2004 | CN1471579A CRIPTO tumour polypeptide |
| 01/28/2004 | CN1471577A Transgenic plants containing molecular decoys that alter protein content therein |
| 01/28/2004 | CN1471359A Agents and method of controllinkg plant foliage diseases |
| 01/28/2004 | CN1470631A Microbe, microbial antivirus product and its use |
| 01/28/2004 | CN1470481A Municipal house refuse termenting method |